Stockscreener 앱 받기
79.66
3.48%
2.68
전일 마감가:
$76.98
열려 있는:
$76.92
하루 거래량:
428.47K
Relative Volume:
0.72
시가총액:
$3.38B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-17.17
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
+9.24%
1개월 성능:
+12.48%
6개월 성능:
+84.44%
1년 성능:
+71.68%
1일 변동 폭
$73.86
$79.88
1주일 범위
$72.80
$82.42
52주 변동 폭
$38.51
$82.42
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
TARS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
79.66 | 3.27B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | Mizuho | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Will Tarsus Pharmaceuticals Inc. stock maintain dividend yieldMarket Trend Summary & Fast Gain Swing Alerts - newser.com
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 (NASDAQ:TARS) - Seeking Alpha
Mizuho Initiates Coverage on Tarsus Pharmaceuticals (TARS) with Outperform Rating | TARS Stock News - GuruFocus
Mizuho initiates coverage on Tarsus Pharmaceuticals stock with Outperform rating - Investing.com Canada
Mizuho Initiates Tarsus Pharmaceuticals at Outperform With $100 Price Target - MarketScreener
Will Tarsus Pharmaceuticals Inc. stock remain a Wall Street favoriteWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Price-Driven Insight from (TARS) for Rule-Based Strategy - news.stocktradersdaily.com
Will Tarsus Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What catalysts could drive Tarsus Pharmaceuticals Inc. stock higherMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offs2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Long term hold vs stop loss in Tarsus Pharmaceuticals Inc.Market Performance Summary & Fast Entry Momentum Alerts - newser.com
Midday Stock Roundup: Eledon Falls after Trial Report - Orange County Business Journal
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD - Investing.com India
Full technical analysis of Tarsus Pharmaceuticals Inc. stockJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com
Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
OC500 2025: BOBAK “BOBBY” AZAMIAN - Orange County Business Journal
What momentum indicators show for Tarsus Pharmaceuticals Inc. stockJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Does Tarsus Pharmaceuticals Inc. fit your quant trading modelJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Top chart patterns to watch in Tarsus Pharmaceuticals Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):